‘Living medicine’ created to tackle drug-resistant lung infections
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria wh...
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria wh...
Endowed with eight million euros, the project is coordinated by Susana Puig, the head of the research group IDIBAPS Melanoma: imaging, genetics and...
IDIBAPS’s Board of Governors has approved the promotion of Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes from Junior Group Leaders...
A study led by the Hospital Clínic-IDIBAPS shows that having a low birth weight limits the body's capacity to adapt when there is another cardiovas...
The results contrast with those of 4 previous independent clinical trials and could provide relevant information on the role of iron accumulation i...
Combining the data obtained from magnetic resonance imaging and the patient's clinical data could make it possible to estimate the relapse risk aft...
The Members’ General Meeting, held to coincide with the Society’s 16th Congress which took place on 24 and 25 November, approved the appointment.
A study by the hospital Clínic Barcelona-IDIBAPS, published in the journal Neurology, confirms the usefulness of a blood-based biomarker to diagnos...
Researchers from the CAPSBE and from IDIBAPS have shown that older adults have difficulty in making use of tele-consult services, and that the incr...